Question 1

Does job-based or Marketplace insurance cover Wegovy?

Accepted Answer

Usually not covered for weight loss: fewer than 1 in 5 large employers (18%) cover drugs like Wegovy for that.

Bigger employers cover them more often (about a third of those with 5,000 or more workers), and plans that cover them require and often a dietitian or lifestyle program. A plan can cover Wegovy to lower heart attack and stroke risk even when it excludes weight loss. Without coverage, Novo Nordisk sells it directly for less than the list price.

Cost: If covered, your plan’s brand-drug copay or coinsurance; if not, Novo Nordisk’s self-pay price (the pen was $349 a month in November 2026).

Question 2

Does Original Medicare cover Wegovy?

Accepted Answer

Yes, for many people with obesity who don’t have type 2 diabetes: Medicare’s GLP-1 Bridge charges $50 a month.

Since July 1, 2026, people with Medicare drug coverage (a plan or a plan with drug coverage) can get Wegovy (injection or pill) for weight loss for a flat $50 a month through the temporary Medicare GLP-1 Bridge. You must be 18 or older and have a BMI of 35 or more, or 30 or more with heart failure (preserved ejection fraction), uncontrolled high blood pressure, or kidney disease stage 3a or worse, or 27 or more with prediabetes, a past heart attack or stroke, or peripheral artery disease. Your prescriber requests prior authorization. You can’t use the Bridge if you have type 2 diabetes, moderate-to-severe sleep apnea, or fatty liver disease (MASH), because your drug plan may cover GLP-1s for those, or if you already filled a GLP-1 through your drug plan in 2026; you pay your plan’s normal cost instead. Your drug plan can also cover Wegovy to lower heart risk in people with heart disease.

Cost: $50 a month through the Bridge; the copay doesn’t count toward your Part D out-of-pocket cap.

Question 3

Does Medicare Advantage cover Wegovy?

Accepted Answer

Yes, for many people with obesity who don’t have type 2 diabetes: Medicare’s GLP-1 Bridge charges $50 a month.

Since July 1, 2026, people with Medicare drug coverage (a plan or a plan with drug coverage) can get Wegovy (injection or pill) for weight loss for a flat $50 a month through the temporary Medicare GLP-1 Bridge. You must be 18 or older and have a BMI of 35 or more, or 30 or more with heart failure (preserved ejection fraction), uncontrolled high blood pressure, or kidney disease stage 3a or worse, or 27 or more with prediabetes, a past heart attack or stroke, or peripheral artery disease. Your prescriber requests prior authorization. You can’t use the Bridge if you have type 2 diabetes, moderate-to-severe sleep apnea, or fatty liver disease (MASH), because your drug plan may cover GLP-1s for those, or if you already filled a GLP-1 through your drug plan in 2026; you pay your plan’s normal cost instead. Your drug plan can also cover Wegovy to lower heart risk in people with heart disease. With Medicare Advantage, this is covered if your plan includes drug coverage (most do), under the same rules.

Cost: $50 a month through the Bridge; the copay doesn’t count toward your Part D out-of-pocket cap.

Question 4

Does Medicaid cover Wegovy?

Accepted Answer

Usually not for weight loss: only about 10 state Medicaid programs cover GLP-1 drugs for obesity in 2026.

Delaware, Kansas, Michigan, Minnesota, Mississippi, North Carolina, Tennessee, Virginia, and Wisconsin cover them, all with (Missouri covers Zepbound instead), and several states, including California, Pennsylvania, and Massachusetts, stopped in 2026. Wegovy to lower heart attack and stroke risk isn’t a weight-loss use, and Medicaid generally covers it for that with prior authorization.

Plan type	How it’s usually covered
Employer or MarketplaceUsually not covered	Usually not covered for weight loss: fewer than 1 in 5 large employers (18%) cover drugs like Wegovy for that. Bigger employers cover them more often (about a third of those with 5,000 or more workers), and plans that cover them require and often a dietitian or lifestyle program. A plan can cover Wegovy to lower heart attack and stroke risk even when it excludes weight loss. Without coverage, Novo Nordisk sells it directly for less than the list price. Cost: If covered, your plan’s brand-drug copay or coinsurance; if not, Novo Nordisk’s self-pay price (the pen was $349 a month in November 2026).
Original MedicareCovered with conditions	Yes, for many people with obesity who don’t have type 2 diabetes: Medicare’s GLP-1 Bridge charges $50 a month. Since July 1, 2026, people with Medicare drug coverage (a plan or a plan with drug coverage) can get Wegovy (injection or pill) for weight loss for a flat $50 a month through the temporary Medicare GLP-1 Bridge. You must be 18 or older and have a BMI of 35 or more, or 30 or more with heart failure (preserved ejection fraction), uncontrolled high blood pressure, or kidney disease stage 3a or worse, or 27 or more with prediabetes, a past heart attack or stroke, or peripheral artery disease. Your prescriber requests prior authorization. You can’t use the Bridge if you have type 2 diabetes, moderate-to-severe sleep apnea, or fatty liver disease (MASH), because your drug plan may cover GLP-1s for those, or if you already filled a GLP-1 through your drug plan in 2026; you pay your plan’s normal cost instead. Your drug plan can also cover Wegovy to lower heart risk in people with heart disease. Cost: $50 a month through the Bridge; the copay doesn’t count toward your Part D out-of-pocket cap.
Medicare AdvantageCovered with conditions	Yes, for many people with obesity who don’t have type 2 diabetes: Medicare’s GLP-1 Bridge charges $50 a month. Since July 1, 2026, people with Medicare drug coverage (a plan or a plan with drug coverage) can get Wegovy (injection or pill) for weight loss for a flat $50 a month through the temporary Medicare GLP-1 Bridge. You must be 18 or older and have a BMI of 35 or more, or 30 or more with heart failure (preserved ejection fraction), uncontrolled high blood pressure, or kidney disease stage 3a or worse, or 27 or more with prediabetes, a past heart attack or stroke, or peripheral artery disease. Your prescriber requests prior authorization. You can’t use the Bridge if you have type 2 diabetes, moderate-to-severe sleep apnea, or fatty liver disease (MASH), because your drug plan may cover GLP-1s for those, or if you already filled a GLP-1 through your drug plan in 2026; you pay your plan’s normal cost instead. Your drug plan can also cover Wegovy to lower heart risk in people with heart disease. With Medicare Advantage, this is covered if your plan includes drug coverage (most do), under the same rules. Cost: $50 a month through the Bridge; the copay doesn’t count toward your Part D out-of-pocket cap.
MedicaidUsually not covered	Usually not for weight loss: only about 10 state Medicaid programs cover GLP-1 drugs for obesity in 2026. Delaware, Kansas, Michigan, Minnesota, Mississippi, North Carolina, Tennessee, Virginia, and Wisconsin cover them, all with (Missouri covers Zepbound instead), and several states, including California, Pennsylvania, and Massachusetts, stopped in 2026. Wegovy to lower heart attack and stroke risk isn’t a weight-loss use, and Medicaid generally covers it for that with prior authorization.

Is Wegovy covered by insurance?

What usually has to be true

Good to know

Related

Sources